+ Follow ANTAGONIST LOSARTAN Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 155123
[Title] => Experts debate genetics vs lifestyle in cardiovascular disease
[Summary] => ATLANTA, Georgia – The influence of genetics and lifestyle on the development of cardiovascular disease was debated at a satellite symposium during the 51st Annual Scientific Session of the American College of Cardiology (ACC 2002).
Dr. Thomas Unger, chairman of the Institute of Pharmacology and Toxicology at Charité, Humboldt University in Berlin, Germany, moderator of the debate, said, "We have been debating genetics versus lifestyle for many years. We know that both factors are involved in cardiovascular disease."
[DatePublished] => 2002-03-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 150837
[Title] => Cost of treating diabetes, kidney failure rising; multi-benefit drug offers hope
[Summary] => The cost of treating diabetes, hypertension and kidney failure is rising steadily and is affecting productivity, prompting health experts to call for more preventive measures.
They said Type-2 diabetes is reaching epidemic proportions and the loss of kidney function associated with diabetes has become the single most common cause of end-stage renal disease (ESRD), or death of the kidney, in many countries, including the United States and the Philippines.
[DatePublished] => 2002-02-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1222905
[AuthorName] => Chat Alejandro
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
ANTAGONIST LOSARTAN
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 155123
[Title] => Experts debate genetics vs lifestyle in cardiovascular disease
[Summary] => ATLANTA, Georgia – The influence of genetics and lifestyle on the development of cardiovascular disease was debated at a satellite symposium during the 51st Annual Scientific Session of the American College of Cardiology (ACC 2002).
Dr. Thomas Unger, chairman of the Institute of Pharmacology and Toxicology at Charité, Humboldt University in Berlin, Germany, moderator of the debate, said, "We have been debating genetics versus lifestyle for many years. We know that both factors are involved in cardiovascular disease."
[DatePublished] => 2002-03-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 150837
[Title] => Cost of treating diabetes, kidney failure rising; multi-benefit drug offers hope
[Summary] => The cost of treating diabetes, hypertension and kidney failure is rising steadily and is affecting productivity, prompting health experts to call for more preventive measures.
They said Type-2 diabetes is reaching epidemic proportions and the loss of kidney function associated with diabetes has become the single most common cause of end-stage renal disease (ESRD), or death of the kidney, in many countries, including the United States and the Philippines.
[DatePublished] => 2002-02-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1222905
[AuthorName] => Chat Alejandro
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
abtest
